Novo Nordisk Foundation Cellerator A/S

CVR 44450569 · Public limited company (A/S) · Active · Low risk

Novo Nordisk Foundation Cellerator A/S is a Public limited company (A/S), founded on , based in Kongens Lyngby. The company is registered in the industry forskning og eksperimentel udvikling inden for naturvidenskab og teknik. Our model estimates a bankruptcy risk of 0.2% over the next 12 months, which is 0.2 times the average for Danish companies. 2 annual reports have been published, of which 1 more than six months after the end of the financial year. The latest annual report (31 Dec 2025) shows equity of DKK 346.5m and a net result of DKK -13.1m. CEO: Thomas Hassing Ronøe Carlsen.

Bankruptcy risk for Novo Nordisk Foundation Cellerator A/S

0.2%
probability of bankruptcy within 12 months
Low risk

0.2 × the average (1.41%) · higher risk than 49% of active Danish companies

Lowest riskHighest risk

Increases the risk

Age (years)2 yrs · bankruptcy rate 18.9%2.1×
Share of late annual reports50%–75% · bankruptcy rate 18.4%2.1×
Published annual reports2 · bankruptcy rate 16.7%1.9×
Time at current address1 yrs · bankruptcy rate 14.0%1.6×
Moves in the last 2 years1 · bankruptcy rate 12.7%1.4×
Website registeredYes · bankruptcy rate 12.0%1.4×
RegionHovedstaden · bankruptcy rate 11.6%1.3×
Annual reports filed late1 · bankruptcy rate 11.3%1.3×

Reduces the risk

Equity vs. share capital5+× · bankruptcy rate 2.5%0.28×
Equity ratio60%+ · bankruptcy rate 3.3%0.38×
Company typeA/S · bankruptcy rate 4.4%0.50×
Auditor registered in CVRYes · bankruptcy rate 4.8%0.55×
Audit opted outNo · bankruptcy rate 4.8%0.55×
Negative equityNo · bankruptcy rate 5.1%0.58×
Capital changes2 · bankruptcy rate 5.2%0.59×
Reporting classReporting class B · bankruptcy rate 5.7%0.65×

The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.

Company details

CVR number
44450569
Status
Active
Company type
Public limited company (A/S)
Founded
(2 years)
Address
Nordvej 250A
2800 Kongens Lyngby
Municipality
Lyngby-Taarbæk
Industry
Forskning og eksperimentel udvikling inden for naturvidenskab og teknik (721000)
Bankruptcies in the industry: Anden forskning og eksperimentel udvikling inden for naturvidenskab og teknik
Share capital
DKK 56.4m
Auditor
PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB
Audit opted out
No

Warning signs

Annual reports filed late1 of 2
Missing annual reportNo
Negative equityNo
Equity ratio88.3%
Current ratio116%
Moves (last 2 years)1
CEO changes in total0
CEO's previous bankruptcies0
Other companies at the address0
Going-concern uncertaintyNo

Financials and key figures

Financial year20252024
Gross profitDKK 3.9mDKK -10.8m
Net profitDKK -13.1mDKK -9.3m
EquityDKK 346.5mDKK 200.5m
Total assetsDKK 392.3mDKK 241.9m
CashDKK 36.4m–
Short-term debtDKK 45.9m–
Avg. employees15–

Latest annual report: Reporting class B · auditor's statement: Den uafhængige revisors erklæring · Pricewaterhousecoopers Statsautoriseret Revisionspartnerselskab.

Filed annual reports

Reporting periodPublishedDays after period end
1 Jan 2025 – 31 Dec 2025105
23 Nov 2023 – 31 Dec 2024189 Late

The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.

Management, owners and auditor

RoleNameFromTo
CEOThomas Hassing Ronøe CarlsenCurrent
BoardPelle Kristoffer Munk-PoulsenCurrent
BoardMads Krogsgaard ThomsenCurrent
BoardTrine HaastrupCurrent
BoardSøren Nedergaard
BoardErika Johanna Söderberg Johnsson
Owner (100%)NOVO NORDISK FONDENCurrent
AuditorPRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKABCurrent
FounderNOVO NORDISK FONDENCurrent
FounderNNF General Partner ApSCurrent

Address history (1 moves)

Nordvej 250A, 2800 Kongens Lyngby
c/o Novo Nordisk Fonden, Tuborg Havnevej 19, 2900 Hellerup

Former names

Novo Nordisk Foundation Cellerator A/S – now
Novo Nordisk Foundation Cellerator P/S –

Similar companies in Lyngby-Taarbæk

Questions and answers about Novo Nordisk Foundation Cellerator A/S

Has Novo Nordisk Foundation Cellerator A/S gone bankrupt?

No, Novo Nordisk Foundation Cellerator A/S is not registered as bankrupt in the CVR register. Its status is: active.

What is the bankruptcy risk of Novo Nordisk Foundation Cellerator A/S?

Our model estimates a bankruptcy risk of 0.2% over the next 12 months (low risk), which is 0.2 times the average for Danish companies.

Who is the CEO of Novo Nordisk Foundation Cellerator A/S?

Thomas Hassing Ronøe Carlsen is the CEO of Novo Nordisk Foundation Cellerator A/S.

Who is the auditor of Novo Nordisk Foundation Cellerator A/S?

Novo Nordisk Foundation Cellerator A/S most recently used PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB.

When was Novo Nordisk Foundation Cellerator A/S founded?

Novo Nordisk Foundation Cellerator A/S was founded on 23 November 2023.

What is the equity of Novo Nordisk Foundation Cellerator A/S?

Equity was DKK 346.5m according to the annual report for the period ending 31 December 2025.

Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.